We will ensure sustainable quality

EU ageing population creates demand for more attention in healthcare and puts high burden on society in terms of costs and loss of quality of life.

Significant part of clinical cases is connected with musculoskeletal disabilities, where implants based on new technologies offer opportunities for lower costs, due to lower amount or revision operations, lower cost of implants and higher performance.

Scientifically, research into biomaterials is done through new techniques, development of new biocompatible materials, additive manufacturing, drug and biomolecule delivery, etc., where research excellence is spread between different organisations specialized in different steps of implant development, leading to lack of collaboration, coordination, fragmentation of funding, and duplication of research projects and infrastructure.

Although research excellence in Latvia is low and Latvia is performing well below EU-average, there is potential in good infrastructure, good existing collaboration between different institutes, international collaboration and alignment with RIS3 (Smart Specialisation Strategy).